Comparing the current results to its competitors, Fonar reported Revenue decrease in the 3 quarter 2026 year on year by -2.55 %, despite the revenue increase by the most of its competitors of 12.15 %, recorded in the same quarter.
The physician and diagnostic management services sector is characterized by significant competition, with numerous large health systems acquiring medical practices, a trend expected to persist. HMCA anticipates increased competition, noting that many competitors possess greater financial and other resources. In the outpatient diagnostic imaging industry, competition focuses on securing physician referrals both locally and through managed care organizations, with advantages such as Upright® MRI scanning. HMCA identifies its main competitors in diagnostic imaging centers as hospitals and independent or management company-owned imaging centers. Key competitive factors include the quality and timeliness of test results and the ability to establish and maintain relationships with referral sources.
Accuray Incorporated is a medical technology company that focuses on the development and sale of radiation therapy systems. Their business model revolves around providing advanced and precise treatment options to cancer patients by combining robotics and imaging technologies. By delivering innovative solutions, Accuray aims to improve patient outcomes and establish partnerships with healthcare providers worldwide.
Edap Tms Sa's business model revolves around providing minimally invasive medical devices and solutions for the treatment of urological diseases, specifically focusing on advanced ultrasound technologies for the diagnosis and treatment of prostate cancer and kidney stones.
GE Healthcare Technologies Inc's business model is focused on providing innovative medical devices, healthcare information technology, and healthcare services to improve patient care and outcomes. The company offers a wide range of products and solutions in areas such as medical imaging, patient monitoring, diagnostics, and healthcare IT. They also collaborate with healthcare providers and partners to offer integrated solutions and support throughout the entire healthcare ecosystem.
Hyperfine Inc operates on a business model that focuses on designing and manufacturing portable and affordable magnetic resonance imaging (MRI) systems, enabling medical professionals to access advanced imaging technology at a lower cost, expanding the reach of MRI diagnostics.
Icad Inc operates on a business model that focuses on the development and commercialization of innovative cancer detection and therapy solutions. They primarily generate revenue through the sale of their advanced medical devices and software solutions to hospitals, clinics, and research institutions worldwide. Their business strategy revolves around continuous innovation, strategic partnerships, and a commitment to providing effective tools for early detection and treatment of cancer.
Sources:
Fonar Corporation’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Fonar Corporation versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
